ZAG-S&W provides advice to life science companies seeking regulatory clearance and to commercialize their products. Many of these companies are at different stages of clinical studies and trials.
Our department handles various commercial agreements relating to clinical studies carried out in medical centers both in Israel and abroad.
.jpg "Insuline Medical Ltd. raised approximately NIS4 million")
.jpg "The firm represented Mazor Robotics Ltd., in a strategic and complex equity investment by Medtronic")
.jpg "Attorneys Oded Har-Even, David Huberman and Robert Condon represented Nano Dimension Ltd.")
.jpg "IATI’s forum of public biomed companies")
.jpg "The firm represented HBL Hadasit Bio-Holdings Ltd. in a fund raising of approximately $1 million")
.jpg "ZAG-S&W Team represented DarioHealth Corp. in a private placement on Nasdaq, in an aggregate price of $5.1 million")
.jpg "Adv. Eran Ben-Dor represented Raziel Therapeutics in a financing round of $4.5 million from Pontifax Ltd.")
.jpg "Our firm represented EasyPark, a Swedish company, in it's acquisition of the Israeli company, Parko")
.jpg "Attorneys Mor Limanovich and Marie Orlovsky represented Zeekit Ltd. in a finanacing round of $9 million")
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rosetta Genomics")
.jpg "Insuline Medical Ltd. raised additional NIS2.2 million")
.jpg "ZAG-S&W represented Aegis Capital Corp. as Lead Placement Agent in a private placement offering of Rennova Health Inc.")
.jpg "The firm represented IceCure Medical Ltd. in a fund raising")
.jpg "ZAG-S&W represented Roth Capital as Underwriter in $8.2 million offering of Light Path Technologies Inc.")
.png "SOHN investment conference")
.jpg "Another successful financing round of $25 million for SimilarWeb")
.jpg "ZAG-S&W represented Roth Capital as underwriter in Top Image System private placecment")
(1).png "Hedge-fund managers gather in Tel Aviv for investment tips and charity")
.jpg "Adv. Mor Limanovich represented NSLComm in a financing round of $2.5 million from JVP and additional investors")
